authors.affiliation: 1 Universitätsklinik für Allgemeine Innere Medizin, Inselspital Bern.
authors.forename: Joëlle
authors.initials: J
authors.lastname: Raschle
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000401:mortality; D000068579:Celecoxib / Q000009:adverse effects* / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D009288:Naproxen / Q000009:adverse effects* / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy*; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D016019:Survival Analysis; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D054328:Proton Pump Inhibitors; D009288:Naproxen; D000068579:Celecoxib; D007052:Ibuprofen